SternAegis Ventures

Menu

 Invest With Us

Issuer Client News

News & Events

INSIGHTEC APPOINTS INDUSTRY LEADER JAKE GHANNAM AS CHIEF COMMERCIAL OFFICER

INSIGHTEC APPOINTS INDUSTRY LEADER JAKE GHANNAM AS CHIEF COMMERCIAL OFFICER

HAIFA, Israel and MIAMI, Sept. 3, 2024 /CNW/ -- Insightec, a global healthcare company dedicated to using focused ultrasound to transform patient care, today announced the appointment of Jake Ghannam as Chief Commercial Officer. In this new role, Ghannam will be responsible for leading commercial operations, driving growth, and spearheading market strategies across global markets.

With an impressive track record, Ghannam brings his expertise in strategic planning and business development to Insightec. His leadership is expected to bolster Insightec's mission of advancing patient care through cutting-edge technologies and solutions.

"At Insightec, we are committed to transforming the paradigm of healthcare with focused ultrasound," said Maurice R. Ferré, M.D., chief executive officer and chairman of the board. "Jake's deep understanding of the sector, combined with his passion for innovation, makes him the perfect fit to lead our commercial strategy and accelerate growth."

Ghannam joins Insightec following time spent at Medtronic and GE HealthCare, where he spearheaded business expansion and innovation initiatives. His impressive track record of success is matched only by his passion for customer-centric solutions.

"I am thrilled to join Insightec at such an exciting time," said Ghannam. "Innovation in healthcare isn't just about breakthroughs – it's about reshaping what's possible. I look forward to leading our talented team, driving innovation, and delivering solutions that make a real difference in patients' lives."

About Insightec

Insightec is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy. The company's Exablate Neuro platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory essential tremor and Parkinson's disease. Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions. Insightec is headquartered in Haifa, Israel, and Miami, with offices in Dallas, Shanghai, and Tokyo.

Follow us on Facebook, LinkedIn and Twitter or visit www.insightec.com for more information.

Forward-looking Statements:

This document contains forward-looking statements regarding, among other things, plans, expectations, and future events. In some cases, forward-looking statements can be identified by the following words: "may," "can," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "promise," "continue," "ongoing," or the negative of these terms. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. Any forward-looking statement is based on information available to Insightec as of the date of the statement. All written or oral forward-looking statements attributable to Insightec are qualified by this caution. Insightec does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Insightec's expectations.

"Exablate," and "Exablate Neuro," as well as the "INSIGHTEC" logo, whether standing alone or in connection with the word "Insightec," are protected trademarks of Insightec.

Photo - https://mma.prnewswire.com/media/2495225/Jake_Ghannam.jpg
Logo - https://mma.prnewswire.com/media/1699588/4888797/Insightec_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/insightec-appoints-industry-leader-jake-ghannam-as-chief-commercial-officer-302237008.html

SOURCE Insightec

Brokerage and investment advisory products and services, are offered through Aegis Capital Corp, a member of FINRA and SIPC. Insurance products are made available through, ACC General Agency, a licensed insurance agency. For those persons inquiring from states where a specific associate is not currently securities and/or insurance licensed, the associate will not transact business in that state or provide follow-up individual responses, until after the associate obtains the appropriate registration in the applicable state.

The information provided should not be relied upon in isolation for the purpose of making an investment decision. You must also consider the objectives, risks, charges, and expenses associated with an investment service, product or strategy prior to making an investment decision. Prior to making any investment or financial decision, an investor should seek advice from a financial, legal, tax and other professional that consider all of the particular facts and circumstances of an investor's situation. The opinions expressed and material provided are for information purposes only and is not an offer, recommendation, or solicitation of any product, strategy or transaction. Any views, strategies or products discussed may not be appropriate or suitable for all individuals and are subject to risks.

Investment and insurance products offered are not insured by the FDIC or any other federal government agency, are not deposits or other obligations of, or guaranteed by, a bank or any bank affiliate, and are subject to investment risks, including possible loss of the principal amount invested.

Check the background of your financial professional on FINRA's BrokerCheck

Form CRS and General Disclosures

Aegis Risk Disclosures